NCT06451328View on ClinicalTrials.gov

Lignosus Rhinoceros TM02® as a Complementary Therapy for Uncontrolled Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions

Asthma

Interventions

DRUG

Lignosus rhinoceros TM02®

Lignosus rhinoceros TM02®

Trial Locations (1)

59100

University of Malaya Medical Centre, Kuala Lumpur

All Listed Sponsors

lead

University of Malaya

OTHER